{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T13:18:19Z","timestamp":1791724699776,"version":"4.3.4"},"reference-count":60,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2024,2,27]],"date-time":"2024-02-27T00:00:00Z","timestamp":1708992000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["21977037"],"award-info":[{"award-number":["21977037"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22377035"],"award-info":[{"award-number":["22377035"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Guangdong National Science Foundation","award":["2022A1515010674"],"award-info":[{"award-number":["2022A1515010674"]}]},{"name":"Guangdong National Science Foundation","award":["2023A1515011750"],"award-info":[{"award-number":["2023A1515011750"]}]},{"DOI":"10.13039\/501100012166","name":"National Key R & D Program of China","doi-asserted-by":"crossref","award":["2017YFA0505100"],"award-info":[{"award-number":["2017YFA0505100"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"name":"International Atomic Energy Agency Coordinated Research Project","award":["25076"],"award-info":[{"award-number":["25076"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,4,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>MDR Staphylococcus aureus infections, along with the severity of biofilm-associated infections, continue to threaten human health to a great extent. It necessitates the urgent development of novel antimicrobial and antibiofilm agents.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>To reveal the mechanism and target of cinacalcet as an antibacterial and antimicrobial agent for S. aureus.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Screening of non-antibiotic drugs for antibacterial and antibiofilm properties was conducted using a small-molecule drug library. In vivo efficacy was assessed through animal models, and the antibacterial mechanism was studied using quantitative proteomics, biochemical assays, LiP-SMap, BLI detection and gene knockout techniques.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Cinacalcet, an FDA-approved drug, demonstrated antibacterial and antibiofilm activity against S. aureus, with less observed development of bacterial resistance. Importantly, cinacalcet significantly improved survival in a pneumonia model and bacterial clearance in a biofilm infection model. Moreover, the antibacterial mechanism of cinacalcet mainly involves the destruction of membrane-targeted structures, alteration of energy metabolism, and production of reactive oxygen species (ROS). Cinacalcet was found to target IcaR, inhibiting biofilm formation through the negative regulation of IcaADBC.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>The findings suggest that cinacalcet has potential for repurposing as a therapeutic agent for MDR S. aureus infections and associated biofilms, warranting further investigation.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jac\/dkae051","type":"journal-article","created":{"date-parts":[[2024,2,27]],"date-time":"2024-02-27T20:20:35Z","timestamp":1709065235000},"page":"903-917","source":"Crossref","is-referenced-by-count":13,"title":["Repurposing cinacalcet suppresses multidrug-resistant <i>Staphylococcus aureus<\/i> by disruption of cell membrane and inhibits biofilm by targeting IcaR"],"prefix":"10.1093","volume":"79","author":[{"given":"Zu-Ye","family":"Fang","sequence":"first","affiliation":[{"name":"MOE Key Laboratory of Tumor Molecular Biology and State Key Laboratory of Bioactive Molecules and Druggability Assessment, Institute of Life and Health Engineering, College of Life Science and Technology, Jinan University , Guangzhou , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-Yuan","family":"Zhang","sequence":"additional","affiliation":[{"name":"MOE Key Laboratory of Tumor Molecular Biology and State Key Laboratory of Bioactive Molecules and Druggability Assessment, Institute of Life and Health Engineering, College of Life Science and Technology, Jinan University , Guangzhou , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Dan","family":"Zheng","sequence":"additional","affiliation":[{"name":"MOE Key Laboratory of Tumor Molecular Biology and State Key Laboratory of Bioactive Molecules and Druggability Assessment, Institute of Life and Health Engineering, College of Life Science and Technology, Jinan University , Guangzhou , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Lei","sequence":"additional","affiliation":[{"name":"MOE Key Laboratory of Tumor Molecular Biology and State Key Laboratory of Bioactive Molecules and Druggability Assessment, Institute of Life and Health Engineering, College of Life Science and Technology, Jinan University , Guangzhou , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianpeng","family":"Zhuang","sequence":"additional","affiliation":[{"name":"MOE Key Laboratory of Tumor Molecular Biology and State Key Laboratory of Bioactive Molecules and Druggability Assessment, Institute of Life and Health Engineering, College of Life Science and Technology, Jinan University , Guangzhou , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Li","sequence":"additional","affiliation":[{"name":"MOE Key Laboratory of Tumor Molecular Biology and State Key Laboratory of Bioactive Molecules and Druggability Assessment, Institute of Life and Health Engineering, College of Life Science and Technology, Jinan University , Guangzhou , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-Yu","family":"He","sequence":"additional","affiliation":[{"name":"MOE Key Laboratory of Tumor Molecular Biology and State Key Laboratory of Bioactive Molecules and Druggability Assessment, Institute of Life and Health Engineering, College of Life Science and Technology, Jinan University , Guangzhou , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuesong","family":"Sun","sequence":"additional","affiliation":[{"name":"MOE Key Laboratory of Tumor Molecular Biology and State Key Laboratory of Bioactive Molecules and Druggability Assessment, Institute of Life and Health Engineering, College of Life Science and Technology, Jinan University , Guangzhou , China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,2,27]]},"reference":[{"key":"2024040202345581200_dkae051-B1","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1128\/CMR.00134-14","article-title":"Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management","volume":"28","author":"Tong","year":"2015","journal-title":"Clin Microbiol Rev"},{"key":"2024040202345581200_dkae051-B2","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nrmicro727","article-title":"Where will new antibiotics come from?","volume":"1","author":"Walsh","year":"2003","journal-title":"Nat Rev Microbiol"},{"key":"2024040202345581200_dkae051-B3","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S1473-3099(17)30753-3","article-title":"Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis","volume":"18","author":"Tacconelli","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"2024040202345581200_dkae051-B4","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis","volume":"399","author":"Antimicrobial Resistance Collaborators","year":"2022","journal-title":"Lancet"},{"key":"2024040202345581200_dkae051-B5","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/nyas.12948","article-title":"Mechanisms of drug resistance: daptomycin resistance","volume":"1354","author":"Tran","year":"2015","journal-title":"Ann N Y Acad Sci"},{"key":"2024040202345581200_dkae051-B6","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nrmicro2415","article-title":"The biofilm matrix","volume":"8","author":"Flemming","year":"2010","journal-title":"Nat Rev Microbiol"},{"key":"2024040202345581200_dkae051-B7","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1128\/JB.186.8.2449-2456.2004","article-title":"The teicoplanin-associated locus regulator (TcaR) and the intercellular adhesin locus regulator (IcaR) are transcriptional inhibitors of the ica locus in Staphylococcus aureus","volume":"186","author":"Jefferson","year":"2004","journal-title":"J Bacteriol"},{"key":"2024040202345581200_dkae051-B8","doi-asserted-by":"crossref","first-page":"3244","DOI":"10.1128\/iai.62.8.3244-3253.1994","article-title":"Characterization of transposon mutants of biofilm-producing Staphylococcus epidermidis impaired in the accumulative phase of biofilm production: genetic identification of a hexosamine-containing polysaccharide intercellular adhesin","volume":"62","author":"Mack","year":"1994","journal-title":"Infect Immun"},{"key":"2024040202345581200_dkae051-B9","doi-asserted-by":"crossref","first-page":"e00026-19","DOI":"10.1128\/MMBR.00026-19","article-title":"Staphylococcal biofilm development: structure, regulation, and treatment strategies","volume":"84","author":"Schilcher","year":"2020","journal-title":"Microbiol Mol Biol Rev"},{"key":"2024040202345581200_dkae051-B10","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/nrd1008","article-title":"Understanding biofilm resistance to antibacterial agents","volume":"2","author":"Davies","year":"2003","journal-title":"Nat Rev Drug Discov"},{"key":"2024040202345581200_dkae051-B11","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1126\/science.284.5418.1318","article-title":"Bacterial biofilms: a common cause of persistent infections","volume":"284","author":"Costerton","year":"1999","journal-title":"Science"},{"key":"2024040202345581200_dkae051-B12","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/nrmicro.2016.94","article-title":"Biofilms: an emergent form of bacterial life","volume":"14","author":"Flemming","year":"2016","journal-title":"Nat Rev Microbiol"},{"key":"2024040202345581200_dkae051-B13","doi-asserted-by":"crossref","first-page":"20200065","DOI":"10.1002\/VIW.20200065","article-title":"Recent development of nanomedicine for the treatment of bacterial biofilm infections","volume":"2","author":"Xiu","year":"2021","journal-title":"View"},{"key":"2024040202345581200_dkae051-B14","doi-asserted-by":"crossref","first-page":"10700","DOI":"10.1039\/D0TB02177F","article-title":"Recent advances in pH-responsive nanomaterials for anti-infective therapy","volume":"8","author":"Lv","year":"2020","journal-title":"J Mater Chem B"},{"key":"2024040202345581200_dkae051-B15","doi-asserted-by":"crossref","first-page":"3875","DOI":"10.1038\/s41467-022-31479-x","article-title":"Potentiating hypoxic microenvironment for antibiotic activation by photodynamic therapy to combat bacterial biofilm infections","volume":"13","author":"Xiu","year":"2022","journal-title":"Nat Commun"},{"key":"2024040202345581200_dkae051-B16","doi-asserted-by":"crossref","first-page":"5898","DOI":"10.1038\/s41467-021-26221-y","article-title":"Addressing MRSA infection and antibacterial resistance with peptoid polymers","volume":"12","author":"Xie","year":"2021","journal-title":"Nat Commun"},{"key":"2024040202345581200_dkae051-B17","doi-asserted-by":"crossref","first-page":"6412","DOI":"10.1002\/anie.202000505","article-title":"Poly(2-oxazoline)-based functional peptide mimics: eradicating MRSA infections and persisters while alleviating antimicrobial resistance","volume":"59","author":"Zhou","year":"2020","journal-title":"Angew Chem Int Ed Engl"},{"key":"2024040202345581200_dkae051-B18","doi-asserted-by":"crossref","first-page":"4792","DOI":"10.1038\/s41467-019-12702-8","article-title":"Enantiomeric glycosylated cationic block co-beta-peptides eradicate Staphylococcus aureus biofilms and antibiotic-tolerant persisters","volume":"10","author":"Zhang","year":"2019","journal-title":"Nat Commun"},{"key":"2024040202345581200_dkae051-B19","doi-asserted-by":"crossref","first-page":"4180","DOI":"10.1021\/acs.nanolett.8b01000","article-title":"Block copolymer nanoparticles remove biofilms of drug-resistant Gram-positive bacteria by nanoscale bacterial debridement","volume":"18","author":"Li","year":"2018","journal-title":"Nano Lett"},{"key":"2024040202345581200_dkae051-B20","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13020-019-0232-2","article-title":"Developing natural products as potential anti-biofilm agents","volume":"14","author":"Lu","year":"2019","journal-title":"Chin Med"},{"key":"2024040202345581200_dkae051-B21","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1021\/acsinfecdis.9b00334","article-title":"Hydrophobicity-modulated small antibacterial molecule eradicates biofilm with potent efficacy against skin infections","volume":"6","author":"Konai","year":"2020","journal-title":"ACS Infect Dis"},{"key":"2024040202345581200_dkae051-B22","doi-asserted-by":"crossref","first-page":"5663","DOI":"10.1128\/AAC.00377-16","article-title":"Screening a commercial library of pharmacologically active small molecules against Staphylococcus aureus biofilms","volume":"60","author":"Torres","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"2024040202345581200_dkae051-B23","doi-asserted-by":"crossref","first-page":"154073","DOI":"10.1016\/j.phymed.2022.154073","article-title":"Phytochemicals with activity against methicillin-resistant Staphylococcus aureus","volume":"100","author":"Liang","year":"2022","journal-title":"Phytomedicine"},{"key":"2024040202345581200_dkae051-B24","doi-asserted-by":"crossref","first-page":"5024","DOI":"10.3390\/molecules25215024","article-title":"Plant derived natural products against Pseudomonas aeruginosa and Staphylococcus aureus: antibiofilm activity and molecular mechanisms","volume":"25","author":"Guzzo","year":"2020","journal-title":"Molecules"},{"key":"2024040202345581200_dkae051-B25","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/534314a","article-title":"Can you teach old drugs new tricks?","volume":"534","author":"Nosengo","year":"2016","journal-title":"Nature"},{"key":"2024040202345581200_dkae051-B26","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.2174\/0929867327666200831141337","article-title":"Perspectives on drug repurposing","volume":"28","author":"Schcolnik-Cabrera","year":"2021","journal-title":"Curr Med Chem"},{"key":"2024040202345581200_dkae051-B27","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/bph.13798","article-title":"Drug repurposing from the perspective of pharmaceutical companies","volume":"175","author":"Cha","year":"2018","journal-title":"Br J Pharmacol"},{"key":"2024040202345581200_dkae051-B28","doi-asserted-by":"crossref","first-page":"106380","DOI":"10.1016\/j.ijantimicag.2021.106380","article-title":"Repositioning of non-antibiotic drugs as an alternative to microbial resistance: a systematic review","volume":"58","author":"Foletto","year":"2021","journal-title":"Int J Antimicrob Agents"},{"key":"2024040202345581200_dkae051-B29","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1093\/jac\/dky555","article-title":"Repurposing ethyl bromopyruvate as a broad-spectrum antibacterial","volume":"74","author":"Kumar","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"2024040202345581200_dkae051-B30","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.3389\/fmicb.2020.01720","article-title":"Repurposing antispasmodic agent otilonium bromide for treatment of Staphylococcus aureus infections","volume":"11","author":"Zhou","year":"2020","journal-title":"Front Microbiol"},{"key":"2024040202345581200_dkae051-B31","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1080\/21505594.2020.1770493","article-title":"Insights into idarubicin antimicrobial activity against methicillin-resistant Staphylococcus aureus","volume":"11","author":"She","year":"2020","journal-title":"Virulence"},{"key":"2024040202345581200_dkae051-B32","first-page":"e146823","article-title":"Repurposing calcium-sensing receptor agonist cinacalcet for treatment of CFTR-mediated secretory diarrheas","volume":"6","author":"Oak","year":"2021","journal-title":"JCI Insight"},{"key":"2024040202345581200_dkae051-B33","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1517\/14656566.2013.777041","article-title":"Cinacalcet hydrochloride for the treatment of hyperparathyroidism","volume":"14","author":"Verheyen","year":"2013","journal-title":"Expert Opin Pharmacother"},{"key":"2024040202345581200_dkae051-B34","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1038\/s41467-019-09186-x","article-title":"Network-based prediction of drug combinations","volume":"10","author":"Cheng","year":"2019","journal-title":"Nat Commun"},{"key":"2024040202345581200_dkae051-B35","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1517\/13543784.13.8.1045","article-title":"Preclinical evaluation of novel antibacterial agents by microbiological and molecular techniques","volume":"13","author":"O\u2019Neill","year":"2004","journal-title":"Expert Opin Investig Drugs"},{"key":"2024040202345581200_dkae051-B36","doi-asserted-by":"crossref","first-page":"eabj2381","DOI":"10.1126\/scitranslmed.abj2381","article-title":"A lipoglycopeptide antibiotic for Gram-positive biofilm-related infections","volume":"14","author":"Blaskovich","year":"2022","journal-title":"Sci Transl Med"},{"key":"2024040202345581200_dkae051-B37","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1124\/jpet.103.057273","article-title":"Pharmacodynamics of the type II calcimimetic compound cinacalcet HCl","volume":"308","author":"Nemeth","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"2024040202345581200_dkae051-B38","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1128\/MMBR.00013-14","article-title":"Biofilm-related infections: bridging the gap between clinical management and fundamental aspects of recalcitrance toward antibiotics","volume":"78","author":"Lebeaux","year":"2014","journal-title":"Microbiol Mol Biol Rev"},{"key":"2024040202345581200_dkae051-B39","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/nrmicro.2017.99","article-title":"Targeting microbial biofilms: current and prospective therapeutic strategies","volume":"15","author":"Koo","year":"2017","journal-title":"Nat Rev Microbiol"},{"key":"2024040202345581200_dkae051-B40","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1093\/jac\/dkh476","article-title":"Comparison of assays for detection of agents causing membrane damage in Staphylococcus aureus","volume":"54","author":"O\u2019Neill","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"2024040202345581200_dkae051-B41","doi-asserted-by":"crossref","first-page":"e2100749","DOI":"10.1002\/advs.202100749","article-title":"Plant natural flavonoids against multidrug resistant pathogens","volume":"8","author":"Song","year":"2021","journal-title":"Adv Sci (Weinh)"},{"key":"2024040202345581200_dkae051-B42","doi-asserted-by":"crossref","first-page":"e1009126","DOI":"10.1371\/journal.ppat.1009126","article-title":"Targeting bioenergetics is key to counteracting the drug-tolerant state of biofilm-grown bacteria","volume":"16","author":"Donnert","year":"2020","journal-title":"PLoS Pathog"},{"key":"2024040202345581200_dkae051-B43","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.cub.2015.11.056","article-title":"Auto poisoning of the respiratory chain by a quorum-sensing-regulated molecule favors biofilm formation and antibiotic tolerance","volume":"26","author":"Hazan","year":"2016","journal-title":"Curr Biol"},{"key":"2024040202345581200_dkae051-B44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/apm.12099","article-title":"The role of bacterial biofilms in chronic infections","volume":"121 Suppl 136","author":"Bjarnsholt","year":"2013","journal-title":"APMIS"},{"key":"2024040202345581200_dkae051-B45","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jcma.2017.07.012","article-title":"Bacterial biofilm and associated infections","volume":"81","author":"Jamal","year":"2018","journal-title":"J Chin Med Assoc"},{"key":"2024040202345581200_dkae051-B46","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1096\/fj.07-9574LSF","article-title":"Dose translation from animal to human studies revisited","volume":"22","author":"Reagan-Shaw","year":"2008","journal-title":"FASEB J"},{"key":"2024040202345581200_dkae051-B47","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2165\/00003495-200565020-00007","article-title":"Cinacalcet hydrochloride","volume":"65","author":"Barman Balfour","year":"2005","journal-title":"Drugs"},{"key":"2024040202345581200_dkae051-B48","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1021\/acsmedchemlett.0c00653","article-title":"Semisynthesis and biological evaluation of platencin thioether derivatives: dual FabF and FabH inhibitors against MRSA","volume":"12","author":"Li","year":"2021","journal-title":"ACS Med Chem Lett"},{"key":"2024040202345581200_dkae051-B49","doi-asserted-by":"crossref","first-page":"3889","DOI":"10.1038\/s41467-021-24151-3","article-title":"Allosteric drug transport mechanism of multidrug transporter AcrB","volume":"12","author":"Tam","year":"2021","journal-title":"Nat Commun"},{"key":"2024040202345581200_dkae051-B50","doi-asserted-by":"crossref","first-page":"16529","DOI":"10.1073\/pnas.1904700116","article-title":"A selective membrane-targeting repurposed antibiotic with activity against persistent methicillin-resistant Staphylococcus aureus","volume":"116","author":"Kim","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2024040202345581200_dkae051-B51","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nrmicro2474","article-title":"Targeting bacterial membrane function: an underexploited mechanism for treating persistent infections","volume":"9","author":"Hurdle","year":"2011","journal-title":"Nat Rev Microbiol"},{"key":"2024040202345581200_dkae051-B52","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1124\/pr.119.018531","article-title":"International union of basic and clinical pharmacology. CVIII. Calcium-sensing receptor nomenclature, pharmacology, and function","volume":"72","author":"Leach","year":"2020","journal-title":"Pharmacol Rev"},{"key":"2024040202345581200_dkae051-B53","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1093\/nar\/gkm1176","article-title":"Crystal structure of IcaR, a repressor of the TetR family implicated in biofilm formation in Staphylococcus epidermidis","volume":"36","author":"Jeng","year":"2008","journal-title":"Nucleic Acids Res"},{"key":"2024040202345581200_dkae051-B54","doi-asserted-by":"crossref","first-page":"13286","DOI":"10.1038\/ncomms13286","article-title":"The antifungal caspofungin increases fluoroquinolone activity against Staphylococcus aureus biofilms by inhibiting N-acetylglucosamine transferase","volume":"7","author":"Siala","year":"2016","journal-title":"Nat Commun"},{"key":"2024040202345581200_dkae051-B55","doi-asserted-by":"crossref","first-page":"8486","DOI":"10.3168\/jds.2015-9899","article-title":"Ethanol extract of Sanguisorba officinalis L. inhibits biofilm formation of methicillin-resistant Staphylococcus aureus in an ica-dependent manner","volume":"98","author":"Chen","year":"2015","journal-title":"J Dairy Sci"},{"key":"2024040202345581200_dkae051-B56","doi-asserted-by":"crossref","first-page":"8617","DOI":"10.1073\/pnas.0913302107","article-title":"Structural study of TcaR and its complexes with multiple antibiotics from Staphylococcus epidermidis","volume":"107","author":"Chang","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2024040202345581200_dkae051-B57","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13756-019-0533-3","article-title":"Antibiotics versus biofilm: an emerging battleground in microbial communities","volume":"8","author":"Sharma","year":"2019","journal-title":"Antimicrob Resist Infect Control"},{"key":"2024040202345581200_dkae051-B58","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1038\/nrd1258","article-title":"Daptomycin","volume":"2","author":"Kirkpatrick","year":"2003","journal-title":"Nat Rev Drug Discov"},{"key":"2024040202345581200_dkae051-B59","doi-asserted-by":"crossref","first-page":"4494","DOI":"10.1128\/JB.00011-12","article-title":"Daptomycin-mediated reorganization of membrane architecture causes mislocalization of essential cell division proteins","volume":"194","author":"Pogliano","year":"2012","journal-title":"J Bacteriol"},{"key":"2024040202345581200_dkae051-B60","doi-asserted-by":"crossref","first-page":"D447","DOI":"10.1093\/nar\/gkv1145","article-title":"2016 update of the PRIDE database and its related tools","volume":"44","author":"Vizcaino","year":"2016","journal-title":"Nucleic Acids Res"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/79\/4\/903\/57130872\/dkae051.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/79\/4\/903\/57130872\/dkae051.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T02:36:32Z","timestamp":1712025392000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/79\/4\/903\/7614994"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,27]]},"references-count":60,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,2,27]]},"published-print":{"date-parts":[[2024,4,2]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkae051","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,4]]},"published":{"date-parts":[[2024,2,27]]}}}